CFS individuals showed increased levels of T regulatory cells (CD25+/FOXP3+) CD4 T cells, and lower proliferative responses in vitro and in vivo. This evidence concerns the gene FOXP3 and myalgic encephalomeyelitis/chronic fatigue syndrome.